Biopol Chemicals IPO Listing at 3.00% Premium at ₹111.00 Per Share

Posted by : Neeraj Pandey | Fri Feb 13 2026

Biopol Chemicals IPO Listing Today: The Biopol Chemicals IPO was subscribed 22.33 times at the time of its closing. In this subscription, qualified institutional buyers (QIBs) received 21.05 times, and non-institutional investors (NIIs) received 24.49 times. The retail quota of the issue was subscribed to 33.25%. Before delving deeper into the topic, go through the details of the Biopol Chemicals IPO.

Table of Contents

Biopol Chemicals IPO

It is a book-building issue IPO of ₹31.26 crore, comprising an entirely fresh issue of 0.29 crore shares. The issue will be listed on NSE and SME on its tentative listing date, 13th February 2026. The Biopol Chemicals IPO date is scheduled from 6th January 2026 to 10th January 2026. The face value of Biopol Chemicals shares stands at ₹10 per share, and the IPO Issue price band is set at ₹102 to ₹108 per share

IPO Allotment Date	11th February 2026
IPO Open Date	6th January 2026
IPO Close Date	10th February 2026
Refund Initiation	12th February 2026
Issue Size	28,94,400 shares(agg. up to ₹31 Cr)
Face Value	₹10 per share
Lot Size	1,200 Shares
Issue Price	₹102 to ₹108 per share
Issue Type	Bookbuilding IPO
Listing At	NSE SME
Listing Date	13th February 2026

Biopol Chemicals Listing

On the NSE & SME platforms, Biopol Chemicals shares are listed at ₹111.00 per share, reflecting a 3.00% premium over the issue price of ₹108 per share.

About the Biopol Chemicals IPO

Biopol Chemicals Limited was incorporated in the year 2023. The company is engaged in the manufacture and trading of speciality chemicals comprising silicones, emulsifiers, biochemicals, and polyelectrolytes. The company’s portfolio of products comprises 66 products, comprising 40 silicone-based products, 5 emulsifier-based products, 15 biochemical-based products, and 6 polyelectrolyte-based products. The products find their applications in the textile, home care, agriculture, and industrial chemicals industries. The company follows a B2B business model wherein the company sells its products to institutional clients and not directly to retail end-consumers. The company operates the 4 establishments located in West Bengal and Gujarat, comprising their manufacturing unit, warehouse, and corporate office in West Bengal, and the registered office located in West Bengal.

Biopol Chemicals Limited Financials

The company’s financial analysis is essential before applying for the Biopol Chemicals IPO. See the table for Biopol Chemicals Limited’s financials.

Year Ended	31st Dec 2025 (in cr.)	31st March 2025 (in cr.)	31st March 2024 (in cr.)
Assets	48.88	31.48	17.56
Revenue	48.97	49.15	17.43
Profit After Tax	6.00	4.33	2.96
EBITDA	8.99	6.53	4.43
Net Worth	19.54	13.53	9.20
Reserves and Surplus	11.63	5.62	1.29
Total Borrowings	14.92	7.69	3.58

Explanation

Biopol Chemicals Limited’s revenue increased by 181.98% from ₹17.43 crores in March 2024 to ₹49.15 crores in March 2025. Moreover, the company’s PAT increased by 46.28% from ₹2.96 crores in March 2024 to ₹4.33 crores in March 2025.